Head and Neck Squamous Cell Carcinoma (HNSCC)
Showing 1 - 20 of 20
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Chengdu (Netopitam Palonosetron capsules and dexamethasone)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Netopitam Palonosetron capsules and dexamethasone
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital and Research Institute
Oct 22, 2023
Malignant Solid Tumor, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial in Worldwide (GEN1042, Pembrolizumab,
Recruiting
- Malignant Solid Tumor
- +5 more
- GEN1042
- +8 more
-
San Diego, California
- +27 more
Dec 24, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in United States (Nivolumab, Cisplatin, Cetuximab)
Completed
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Nivolumab
- +3 more
-
Palo Alto, California
- +10 more
Nov 22, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Worldwide (BI 765063, Ezabenlimab, BI 836880)
Recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- BI 765063
- +4 more
-
Saint Louis, Missouri
- +15 more
Aug 10, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in New York (Adjuvant hypofractionation, Definitive Hypofractionation)
Enrolling by invitation
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Adjuvant hypofractionation
- Definitive Hypofractionation
-
New York, New York
- +3 more
Aug 1, 2022
Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)
Not yet recruiting
- Locally Advanced or Metastatic Solid Tumors
- +3 more
- (no location specified)
Jul 24, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Canada, United States (Pembrolizumab, Stereotactic Body Radiation Therapy
Recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Pembrolizumab
- Stereotactic Body Radiation Therapy (SBRT)
-
Tucson, Arizona
- +18 more
Jul 18, 2022
Human Papillomavirus (HPV), Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in New York (radiation, other, drug)
Withdrawn
- Human Papillomavirus (HPV)
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- RT 50 Gy
- +6 more
-
New York, New YorkMount Sinai Hospital
Jul 1, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Nivolumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 31, 2022
NSCLC (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC), Hepatocellular Carcinoma (HCC) Trial in Canada, United States
Active, not recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +2 more
-
Beverly Hills, California
- +5 more
Mar 28, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in United States (Nivolumab, Stereotactic Body Radiation Therapy (SBRT))
Completed
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Nivolumab
- Stereotactic Body Radiation Therapy (SBRT)
-
Basking Ridge, New Jersey
- +5 more
Feb 15, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Seoul (Nivolumab)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
-
Seoul, Korea, Republic ofYonsei Severance Hospital
Jan 27, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Worldwide (Ulevostinag, Pembrolizumab)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Ulevostinag
- Pembrolizumab
-
Los Angeles, California
- +33 more
Oct 4, 2021
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Head and Neck Carcinoma Trial in Pittsburgh (Avmacol)
Completed
- Head and Neck Cancer
- +8 more
- Avmacol
-
Pittsburgh, Pennsylvania
- +1 more
Apr 7, 2021
Premalignant Lesion, Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in France (Samples collection, Psychological and
Terminated
- Premalignant Lesion
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Samples collection
- +3 more
-
Annecy, France
- +9 more
Oct 6, 2020
Non Small Cell Lung Cancer Squamous (NSCLC-Sq), Head and Neck Squamous Cell Carcinoma (HNSCC), Small Cell Lung Cancer (SCLC)
Completed
- Non Small Cell Lung Cancer Squamous (NSCLC-Sq)
- +5 more
-
Huntersville, North Carolina
- +2 more
Dec 27, 2019
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Nice (TPF2, Radiotherapy with carboplatin)
Withdrawn
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- TPF2
- Radiotherapy with carboplatin
-
Nice, FrancePEYRADE Frédéric
Apr 4, 2019
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Semi-allogenic human fibroblast (MRC-5) transfected with DNA)
Withdrawn
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Semi-allogenic human fibroblast (MRC-5) transfected with DNA
-
Pittsburgh, Pennsylvania
- +2 more
Sep 4, 2017
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in United States (Lymphoseek)
Terminated
- Head and Neck Squamous Cell Carcinoma (HNSCC)
-
Birminham, Alabama
- +12 more
Aug 6, 2014